Which of the following could indicate central nervous system (CNS) toxicity?
A. Nausea, vomiting, and diarrhea
B. Dizziness, blurred vision, and slurred speech
C. Hyperactivity, hostility, and confusion
D. None of the above
Answer: B
You might also like to view...
An older patient is started on spironolactone to control hypertension. The nurse knows to monitor for
a. hyperkalemia. c. confusion. b. irregular heart rate. d. pulmonary edema.
A client scheduled to have a uroflowmetry asks the nurse why the test is being done. The nurse should explain that the test:
1. will determine the presence of bladder tumors. 2. is used to evaluate urinary retention and incontinence. 3. can identify types of bladder infections. 4. can evaluate the need for urethral surgery.
You are called in to help out in the ED where three UPS workers have just arrived by ambulance that was involved in a package being dropped, discharging a white powder into the air
Two of the workers inhaled the powder and got it on their skin and uniforms. Victim 1, who was catching the box tossed when it dropped, is in respiratory distress, coughing, and wheezing. He states he may also have swallowed some of the substance. Victim 2 has a rash with blisters on his face, hands, and arms. He also inhaled some of the white substance when the box broke open. Victim 3 was a little farther away unloading the van and only inhaled the substance. a. You are to triage these three clients and decide who the physician sees first. What levels would you triage these victims? b. What is your assessment of victim 1, victim 2, and victim 3? c. What treatment do you suggest for victim 1? d. What treatment for victim 2? e. What treatment would you decide for victim 3? f. What are the three pathogens that can be used by terrorists as biological weapons that are also pathogens that can cause humans disasters?
A nurse is discussing how drugs are approved with a health care provider. Place the stages of approval for therapeutic and biological drugs in the appropriate sequence
1. NDA submission with review 2. Preclinical investigation 3. Clinical investigation 4. Post-marketing studies